Orig3n
FDA Grants EUAs to Coronavirus Tests From Orig3n, SDI, UNC
The FDA has also granted emergency use authorization for PCR-based tests for SARS-CoV-2 developed by Orig3n, Specialty Diagnostic Laboratories (SDI), and the University of North Carolina (UNC) Medical Center.
Orig3n's Purchase of Interleukin's CLIA Lab May Appease CMS, But Some Question Plans for Test Assets
Premium
A number of experts have questioned the clinical validity underlying Interleukin's tests and hope Orig3n will not revive them.
Orig3n Acquires Interleukin Genetics CLIA Lab, Remaining Assets
Interleukin said in July that it would liquidate its assets after laying off 63 percent of its workforce and suspending sales of its controversial genetic test.
Dental Association Advances Resolution on Genetic Test Validity
The American Dental Association wants insurers and test manufacturers to show genetic testing is scientifically valid before they're used to determine coverage eligibility.
Interleukin Genetics to Liquidate Assets
The announcement comes three weeks after Interleukin said it was laying off 63 percent of its workforce and suspending sales of a controversial genetic test.